Karus CSO presents at major industry conference

Southampton, UK – 20 October 2008 – Innovative pharmaceutical company Karus Therapeutics Ltd has today announced that the company’s Chief Scientific Officer, Dr Stephen Shuttleworth, will be making a presentation at CHI’s Second Annual HDAC Inhibitors meeting in Boston, MA. This meeting is part of the Discovery on Target conference and brings together research and […]

Karus CEO talks to Pharma TV

Karus CEO talks to Pharma TV

Ann Hacker joins Karus board

Southampton, UK – 2 April 2008 – Innovative pharmaceutical company Karus Therapeutics Ltd has today announced that Ann Hacker has joined the company’s board as an independent non-executive director. Ann brings substantial experience of senior management and corporate governance gained in major pharmaceutical and VC-backed biotechnology companies, which will support Karus’s continued growth and success. […]

Karus appoints Stephen Shuttleworth as Chief Scientific Officer

Southampton, UK – 1 January 2008 – Innovative pharmaceutical company Karus Therapeutics Ltd has today announced the appointment of Dr Stephen J Shuttleworth FRSC to the position of Chief Scientific Officer. Dr Shuttleworth brings substantial R&D management experience gained from major life-science companies on both sides of the Atlantic and will play a key part […]